Filing Details
- Accession Number:
- 0001567619-20-019111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 19:01:54
- Reporting Period:
- 2020-11-06
- Accepted Time:
- 2020-11-10 19:01:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-06 | 283 | $466.86 | 716,178 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 900 | $468.17 | 715,278 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 1,899 | $469.76 | 713,379 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 1,688 | $470.44 | 711,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 1,700 | $471.34 | 709,991 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,000 | Indirect | by Ayers Family Trust |
Footnotes
- Represents the weighted average price of the shares sold ranging from a low of $466.732 to a high of $467.165 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $467.87 to a high of $468.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $469.112 to a high of $470.11 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $470.12 to a high of $471.03 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $471.16 to a high of $471.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
